Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Bvf Inc | 10.33M (45.63%) | 0.00 Increased by 0.00% | Mar 31, 25 |
2 | Blue Owl Capital Holdings LP | 3.44M (15.21%) | 0.00 Increased by 0.00% | Mar 31, 25 |
3 | Orbimed Advisors, LLC | 3.32M (14.67%) | 0.00 Increased by 0.00% | Mar 31, 25 |
4 | CHI Advisors LLC | 2.97M (13.10%) | -32.06K Decreased by -1.08% | Sep 30, 23 |
5 | Versant Venture Management LLC | 2.65M (11.69%) | 0.00 Increased by 0.00% | Mar 31, 25 |
6 | Redmile Group, LLC | 1.88M (8.32%) | -31.70K Decreased by -1.68% | Mar 31, 25 |
7 | T. Rowe Price Investment Management,Inc. | 1.80M (7.93%) | -106.30K Decreased by -5.92% | Sep 30, 23 |
8 | Aquilo Capital Management, LLC | 1.29M (5.71%) | 0.00 Increased by 0.00% | Mar 31, 25 |
9 | ARK Investment Management LLC | 1.12M (4.97%) | -875.51K Decreased by -77.86% | Mar 31, 25 |
10 | Mpm Asset Management, LLC | 1.12M (4.95%) | -562.39K Decreased by -50.15% | Mar 31, 25 |
11 | FMR Inc | 1.08M (4.77%) | -88.56K Decreased by -8.20% | Sep 30, 23 |
12 | Citadel Advisors Llc | 937.49K (4.14%) | 937.49K Increased by +100.00% | Mar 31, 25 |
13 | Deep Track Capital, LP | 904.26K (3.99%) | -1.78M Decreased by -196.86% | Jun 30, 24 |
14 | MPM Oncology Impact Management LP | 819.92K (3.62%) | -411.23K Decreased by -50.15% | Mar 31, 25 |
15 | Artal Group S A | 700.00K (3.09%) | 0.00 Increased by 0.00% | Mar 31, 24 |
16 | Acadian Asset Management LLC | 640.33K (2.83%) | 640.33K Increased by +100.00% | Mar 31, 25 |
17 | Logos Global Management LP | 600.00K (2.65%) | 300.00K Increased by +50.00% | Dec 31, 23 |
18 | Ensign Peak Advisors Inc | 344.33K (1.52%) | 0.00 Increased by 0.00% | Mar 31, 24 |
19 | Renaissance Technologies Corp | 298.66K (1.32%) | -48.80K Decreased by -16.34% | Mar 31, 25 |
20 | Northern Trust Corp | 292.36K (1.29%) | 292.36K Increased by +100.00% | Mar 31, 25 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | ARK Genomic Revolution ETF | 1.13M (4.98%) | -1.65K Decreased by -0.15% | Mar 31, 25 |
2 | ARK Genomic Revolution | 1.10M (4.87%) | -872.23K Decreased by -79.10% | Mar 31, 25 |
3 | FIAM Small Cap Core Composite | 766.50K (3.38%) | -10.90K Decreased by -1.42% | Sep 30, 23 |
4 | T. Rowe Price Small-Cap Value | 615.14K (2.72%) | -107.80K Decreased by -17.52% | Sep 30, 23 |
5 | FIAM Small Cap Core CIT Cl B | 559.09K (2.47%) | -207.41K Decreased by -37.10% | Oct 31, 23 |
6 | T. Rowe Price Small-Cap Stock | 380.70K (1.68%) | -500.00 Decreased by -0.13% | Sep 30, 23 |
7 | T. Rowe Price US Small-Cap Core Equity | 380.70K (1.68%) | -500.00 Decreased by -0.13% | Sep 30, 23 |
8 | T. Rowe Price U.S. SC Value Eq Tr-Z | 298.21K (1.32%) | 300.00 Increased by +0.10% | Sep 30, 23 |
9 | Nikko Gbl All Biological Genome Eq MF | 297.64K (1.31%) | -28.36K Decreased by -9.53% | Jun 7, 24 |
10 | T. Rowe Price Instl Small-Cap Stock | 212.40K (0.94%) | 0.00 Increased by 0.00% | Sep 30, 23 |
11 | T. Rowe Price U.S. SC Core Eq Tr-Z | 178.71K (0.79%) | 500.00 Increased by +0.28% | Sep 30, 23 |
12 | A4Investments SICAV SIF ACCI IlanaA2EURH | 160.00K (0.71%) | 0.00 Increased by 0.00% | Jan 31, 25 |
13 | MEDICAL BioHealth EUR Acc | 144.57K (0.64%) | -38.48K Decreased by -26.62% | Oct 31, 23 |
14 | Northern Small Cap Core I | 92.06K (0.41%) | 92.06K Increased by +100.00% | Mar 31, 25 |
15 | Vanguard Health Care ETF | 52.52K (0.23%) | 231.00 Increased by +0.44% | May 31, 25 |
16 | Biotech Growth Ord | 49.26K (0.22%) | 0.00 Increased by 0.00% | Feb 28, 25 |
17 | Range Cancer Therapeutics ETF | 47.41K (0.21%) | 0.00 Increased by 0.00% | Mar 31, 25 |
18 | NT Quality SCC US Fund - L | 47.20K (0.21%) | 47.20K Increased by +100.00% | Mar 31, 25 |
19 | NT Quality Small Cap Core | 47.20K (0.21%) | 47.20K Increased by +100.00% | Mar 31, 25 |
20 | Harbor Disruptive Innovation Instl | 42.65K (0.19%) | 10.50K Increased by +24.62% | Mar 31, 24 |